E.l.f. Beauty, Inc. says retailer CVS will more than double its shelf space in US stores in spring 2024, while Walmart will provide more space for the e.l.f. brand this summer. In a 6 February earnings report, the Oakland, Calif.-based firm reported its sales jumped 86% in the fiscal third quarter to $270.9m.
E.l.f. Beauty, Inc.’s strong and sustained quarterly growth shows no sign of slowing and its retail partners have taken notice, with plans to grow e.l.f. shelf space in major US retail doors in coming months.
The Oakland, Calif.-based firm’s sales soared 86% to $270.9m in its fiscal 2024 third quarter (September-December), according to the company’s...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
